Yes, children with allergies, asthma, and eczema can and should receive MMR and varicella vaccines
Children with allergies, asthma, and eczema are not contraindicated from receiving MMR and varicella vaccines—these conditions do not increase the risk of serious vaccine reactions, and vaccination should proceed according to standard schedules. 1
Key Evidence Supporting Vaccination
Allergies Are Not a Contraindication
The ACIP guidelines explicitly state that minor illnesses and common allergic conditions are not contraindications for MMR vaccination 1. The critical distinction is between:
- Anaphylactic reactions to vaccine components (true contraindication)
- Common allergic conditions like asthma, eczema, or food allergies (NOT contraindications)
Egg Allergy Specifically Addressed
Even children with anaphylactic reactions to eggs can safely receive MMR vaccine without special protocols or skin testing 1. Recent evidence demonstrates that anaphylactic reactions to measles-containing vaccines are not associated with egg antigens but with other vaccine components (potentially gelatin). The risk of serious allergic reactions in egg-allergic patients is extremely low 1.
Research confirms this: A study of 135 allergic children (including 68 with eczema, 47 with asthma) showed 95% were safely vaccinated with MMR, with only mild reactions (urticaria or fever) in 2 patients 2.
Asthma and Eczema Do Not Increase Risk
Large-scale evidence shows no increased risk of vaccine reactions in children with asthma or eczema 2. In fact, meta-analysis suggests measles vaccination may be associated with reduced risk of eczema (RR 0.65) and asthma (RR 0.78) 3.
Vaccination Schedule Recommendations
Standard Timing
- First dose: 12-15 months
- Second dose: 4-6 years 4
Vaccine Options
For first dose (12-47 months):
- Preferred: MMR + varicella as separate injections (unless parent prefers MMRV)
- MMRV combination vaccine carries slightly higher febrile seizure risk (1 extra per 2,300-2,600 doses) 4
For second dose or first dose ≥48 months:
- MMRV combination generally preferred (fewer injections, better compliance) 4
Special Consideration: Personal/Family History of Seizures
If the child has a personal or family history of seizures (any type), use MMR + varicella as separate injections rather than MMRV 4. This is a precaution, not a contraindication—the child should still be vaccinated.
True Contraindications to Consider
The following are actual contraindications (allergies, asthma, and eczema are NOT on this list):
- Severe immunosuppression (high-dose corticosteroids, chemotherapy, severe HIV)
- Pregnancy (theoretical risk to fetus)
- Previous anaphylactic reaction to vaccine components (gelatin, neomycin)
- Moderate to severe acute febrile illness (defer until recovered) 1
Practical Implementation
Pre-Vaccination Assessment
Ask specifically about:
- Previous anaphylactic reactions to vaccines or vaccine components (not just "allergies")
- Current moderate/severe febrile illness
- Personal or family history of seizures (affects MMRV vs. separate vaccine choice)
- Immunosuppression status
Do NOT delay vaccination for:
- Well-controlled asthma
- Eczema (any severity)
- Food allergies (including egg)
- Mild upper respiratory infections
- Low-grade fever 1
Post-Vaccination Monitoring
- Standard 15-minute observation period
- Monitor for fever days 5-12 post-vaccination (when febrile reactions typically occur)
- Counsel parents that mild fever and rash are common, expected reactions
Common Pitfalls to Avoid
- Do not require egg skin testing before MMR vaccination—this is outdated practice 1
- Do not defer vaccination because of eczema or asthma—these are not contraindications
- Do not confuse mild allergic conditions with true anaphylaxis—only anaphylactic reactions to vaccine components are contraindications
- Do not use MMRV for first dose in children with seizure history—use separate MMR + varicella instead 4
Effectiveness and Safety Data
- Measles effectiveness: 95% after one dose, 96% after two doses 5
- Mumps effectiveness: 72% after one dose, 86% after two doses 5
- Varicella effectiveness: 95% after two doses 5
- Serious adverse events are extremely rare: only 33 anaphylactic reactions reported after >70 million MMR doses distributed 1
The benefit-risk profile strongly favors vaccination in children with allergies, asthma, and eczema—natural infection with these diseases carries far greater morbidity and mortality risk than vaccination.